Chemical synthesis and biological activities of analogues of 2',5'-oligoadenylates containing 8-substituted adenosine derivatives.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Nucleic Acids Research

• Publication date

  1990-08-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/NAR/18.15.4439PMID 2167468PMCID PMC331262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NMR of proteins and nucleic acids

  1988cited by this paper
• Principles of nuclear magnetic resonance in one and two dimensions

  1987cited by this paper
• Purine 8-bromination modulates the ribonuclease L binding and activation abilities of 2',5'-oligoadenylates. Possible influence of glycosyl torsion angle.

  1987cited by this paper
• Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.

  1987cited by this paper
• Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine.

  1986cited by this paper
• Molecular mechanism of codon recognition by tRNA species with modified uridine in the first position of the anticodon.

  1985cited by this paper
• Replacement of the ribofuranose oxygen of 2-5A derivatives by methylene: synthesis of an aristeromycin analogue of 2-5A core 5'-monophosphate (5'-O-phosphoryladenylyl)(2'----5')adenyl(2'----5')adenosine.

  1985cited by this paper
• n-Decyl-NHpppA2'p5'A2'p5'A A phosphatase-resistant, active pppA2'p5'A2'p5'A analog.

  1985cited by this paper
• Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.

  1985cited by this paper
• Synthesis and biological activity of tubercidin analogues of ppp5'A2'p(5'A2'p)n5'A.

  1984cited by this paper
• Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine to the 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine dependent endoribonuclease: chain length, phosphorylation state, and heterocyclic base.

  1984cited by this paper
• Synthesis and biological activity of 5'-capped derivatives of 5'-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine.

  1984cited by this paper
• 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 1. Substrate specificity of the interferon-induced murine 2',5'-oligoadenylate synthetase and enzymatic synthesis of oligomers.

  1983cited by this paper
• Cordycepin analogues of 2-5A and its derivatives. Chemical synthesis and biological activity.

  1983cited by this paper
• Analogues and analogue inhibitors of ppp(A2'p)nA. Their stability and biological activity.

  1983cited by this paper
• Synthesis and biological activity of a fluorescent analogue of 2—5A

  1983cited by this paper
• Xyloadenosine analogue of (A2′p)2A inhibits replication of herpes simplex viruses 1 and 2

  1983cited by this paper
• Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activity.

  1982cited by this paper
• Chemical modification potentiates the biological activities of 2-5A and its congeners.

  1982cited by this paper
• Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts.

  1982cited by this paper
• Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

  1981cited by this paper
• Radiosensitizing effect of 2,4-dinitroimidazole-1-ethanol and its cytotoxicity in HeLa S3 cells.

  1981cited by this paper
• Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells.

  1981cited by this paper
• Radioimmune and radiobinding assays for A2'p5'A2'p5'A, pppA2'p5'A, and related oligonucleotides.

  1981cited by this paper
• Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.

  1981cited by this paper
• Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells.

  1979cited by this paper
• pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

  1978cited by this paper
• Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA.

  1978cited by this paper
• Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.

  1978cited by this paper
• Interferon action: Isolation of Nuclease F, A translation inhibitor activated by interferon‐induced (2′–5′) oligo‐isoadenylate

  1978cited by this paper
• Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

  1978cited by this paper
• Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A

  1978cited by this paper
• Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells

  1977cited by this paper
• Studies on the conformation of purine nucleosides and their 5'-phosphates.

  1972cited by this paper

• Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology

  2022cites this paper
• Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.

  2016cites this paper
• 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.

  2010cites this paper
• Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.

  2003cites this paper
• A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.

  1995cites this paper
• Inhibition of HIV-1 Replication and Activation of RNase L by Phosphorothioate/Phosphodiester 2′,5′-Oligoadenylate Derivatives (*)

  1995cites this paper
• Conformation analysis of 3'-fluorinated A(2'-5')A(2'-5')A fragments. Relation between conformation and biological activity.

  1994cites this paper
• Chemical synthesis of 2',5'-oligoadenylate analogues.

  1994cites this paper
• Preparation of cyclic 2',3'-monophosphates of oligoadenylates (A2'p)nA > p and A3'p(A2'p)n-1A > p.

  1994cites this paper
• Biological Response Modifiers — Interferons, Double-Stranded RNA and 2′,5′-Oligoadenylates

  1994cites this paper
• Conformational analysis of 3'-fluorinated A(2'-5')A(2'-5')A fragments: Relation between conformation and biological activity

  1994cites this paper
• Synthesis of new modified 2′,5′-adenylate trimers carrying 3′-amino-3′-deoxyadenosine at the 2′-terminus

  1994cites this paper
• The Relationship between Conformation and Biological Activity of 8-substituted Analogues of 2′,5′-Oligoadenylates

  1994cites this paper
• Characterization and biological activity of 8-substituted analogues of 2',5'-oligoadenylates.

  1993cites this paper
• Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.

  1993cites this paper
• A new and potent 2-5A analogue which does not require a 5'-polyphosphate to activate mouse L-cell RNase L.

  1992cites this paper
• Purine 8-substitution modulates the ribonuclease L binding and activation abilities of 2',5'-oligoadenylates.

  1991cites this paper
• 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.

  1991cites this paper